Sunday, 26 December 2010

Dipentum


Generic Name: olsalazine (ole SAL a zeen)

Brand Names: Dipentum


What is Dipentum (olsalazine)?

Olsalazine affects substances in the body that cause inflammation, tissue damage, and diarrhea.


Olsalazine is used to treat ulcerative colitis.


Olsalazine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dipentum (olsalazine)?


You should not use this medication if you are allergic to olsalazine or to salicylates such as aspirin, Novasal, Doan's Extra Strength, Salflex, Tricosal, and others.

Before taking olsalazine, tell your doctor if you have asthma or other allergies, kidney disease, or liver disease.


Call your doctor at once if your colitis symptoms get worse, or if you have chest pain, shortness of breath, fast or pounding heartbeats, nausea, stomach pain, loss of appetite, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

What should I discuss with my healthcare provider before taking Dipentum (olsalazine)?


You should not use this medication if you are allergic to olsalazine or to salicylates such as aspirin, Novasal, Doan's Extra Strength, Salflex, Tricosal, and others.

Before taking olsalazine, tell your doctor if you are allergic to any drugs, or if you have:



  • asthma or other allergies;




  • kidney disease; or




  • liver disease.



If you have any of these conditions, you may need a dose adjustment or special tests to safely take olsalazine.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Olsalazine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Dipentum (olsalazine)?


Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Take olsalazine with a full glass of water. Store olsalazine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include nausea, vomiting, and diarrhea.


What should I avoid while taking Dipentum (olsalazine)?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using olsalazine.


Avoid getting a varicella (chickenpox) vaccine within 6 weeks after you stop taking olsalazine.


Dipentum (olsalazine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using olsalazine and call your doctor at once if you have any of these serious side effects:

  • worsening colitis (fever, stomach pain, cramping, or bloody diarrhea);




  • chest pain, shortness of breath, fast or pounding heartbeats; or




  • nausea, stomach pain, loss of appetite, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • mild stomach discomfort;




  • nausea, heartburn;




  • skin rash, itching;




  • headache;




  • muscle or joint pain; or




  • urinating more often than usual.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dipentum (olsalazine)?


The following drugs can interact with olsalazine. Tell your doctor if you are using any of these:



  • a blood thinner such as warfarin (Coumadin);




  • thioguanine; or




  • mercaptopurine (Purinethol).



This list is not complete and there may be other drugs that can interact with olsalazine. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Dipentum resources


  • Dipentum Side Effects (in more detail)
  • Dipentum Use in Pregnancy & Breastfeeding
  • Drug Images
  • Dipentum Drug Interactions
  • Dipentum Support Group
  • 0 Reviews for Dipentum - Add your own review/rating


  • Dipentum Prescribing Information (FDA)

  • Dipentum Monograph (AHFS DI)

  • Dipentum Advanced Consumer (Micromedex) - Includes Dosage Information

  • Dipentum MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dipentum with other medications


  • Ankylosing Spondylitis
  • Ulcerative Colitis
  • Ulcerative Colitis, Active
  • Ulcerative Colitis, Maintenance


Where can I get more information?


  • Your pharmacist can provide more information about olsalazine.

See also: Dipentum side effects (in more detail)


Sunday, 19 December 2010

Lizinopril




Lizinopril may be available in the countries listed below.


Ingredient matches for Lizinopril



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lizinopril in the following countries:


  • Croatia (Hrvatska)

Lisinopril

Lisinopril is reported as an ingredient of Lizinopril in the following countries:


  • Croatia (Hrvatska)

  • Serbia

  • Slovenia

International Drug Name Search

Saturday, 18 December 2010

Sertralina Aphar




Sertralina Aphar may be available in the countries listed below.


Ingredient matches for Sertralina Aphar



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Aphar in the following countries:


  • Spain

International Drug Name Search

Monday, 13 December 2010

Ciclosol




Ciclosol may be available in the countries listed below.


Ingredient matches for Ciclosol



Ciclosporin

Ciclosporin is reported as an ingredient of Ciclosol in the following countries:


  • Switzerland

International Drug Name Search

Friday, 10 December 2010

Cusicrom




Cusicrom may be available in the countries listed below.


Ingredient matches for Cusicrom



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Cusicrom in the following countries:


  • Bahrain

  • Bulgaria

  • Czech Republic

  • Georgia

  • Oman

  • Poland

  • Taiwan

International Drug Name Search

Amoxicillinum




Amoxicillinum may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxicillinum



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillinum in the following countries:


  • Poland

International Drug Name Search

Monday, 6 December 2010

Mulcatel




Mulcatel may be available in the countries listed below.


Ingredient matches for Mulcatel



Sucralfate

Sucralfate is reported as an ingredient of Mulcatel in the following countries:


  • Chile

International Drug Name Search

Saturday, 4 December 2010

Cefaperos




Cefaperos may be available in the countries listed below.


Ingredient matches for Cefaperos



Cefatrizine

Cefatrizine comp. with propylene glycole (a derivative of Cefatrizine) is reported as an ingredient of Cefaperos in the following countries:


  • Luxembourg

International Drug Name Search

Zopimerck




Zopimerck may be available in the countries listed below.


Ingredient matches for Zopimerck



Eszopiclone

Zopiclone is reported as an ingredient of Zopimerck in the following countries:


  • Romania

International Drug Name Search

Thursday, 2 December 2010

Ceftazidim Mylan




Ceftazidim Mylan may be available in the countries listed below.


Ingredient matches for Ceftazidim Mylan



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Ceftazidim Mylan in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, 24 November 2010

Ciplabude




Ciplabude may be available in the countries listed below.


Ingredient matches for Ciplabude



Budesonide

Budesonide is reported as an ingredient of Ciplabude in the following countries:


  • Colombia

International Drug Name Search

Sunday, 21 November 2010

Brionot




Brionot may be available in the countries listed below.


Ingredient matches for Brionot



Piroxicam

Piroxicam is reported as an ingredient of Brionot in the following countries:


  • Argentina

International Drug Name Search

Macmiror




Macmiror may be available in the countries listed below.


Ingredient matches for Macmiror



Nifuratel

Nifuratel is reported as an ingredient of Macmiror in the following countries:


  • Bulgaria

  • Czech Republic

  • Georgia

  • Hong Kong

  • Italy

  • Lithuania

  • Mexico

  • Poland

  • Romania

  • Russian Federation

  • Slovakia

  • Taiwan

Nystatin

Nystatin is reported as an ingredient of Macmiror in the following countries:


  • Slovakia

International Drug Name Search

Monday, 15 November 2010

Carnyl Acetylsalicylsyre




Carnyl Acetylsalicylsyre may be available in the countries listed below.


Ingredient matches for Carnyl Acetylsalicylsyre



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Carnyl Acetylsalicylsyre in the following countries:


  • Denmark

International Drug Name Search

Cefantral




Cefantral may be available in the countries listed below.


Ingredient matches for Cefantral



Cefotaxime

Cefotaxime is reported as an ingredient of Cefantral in the following countries:


  • Ethiopia

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Cefantral in the following countries:


  • Myanmar

International Drug Name Search

Saturday, 13 November 2010

MonoFIX-VF




MonoFIX-VF may be available in the countries listed below.


Ingredient matches for MonoFIX-VF



Coagulation Factor IX, Human

Coagulation Factor IX, Human is reported as an ingredient of MonoFIX-VF in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Tuesday, 9 November 2010

Ciclosporina Depronal




Ciclosporina Depronal may be available in the countries listed below.


Ingredient matches for Ciclosporina Depronal



Ciclosporin

Ciclosporin is reported as an ingredient of Ciclosporina Depronal in the following countries:


  • Spain

International Drug Name Search

Saturday, 6 November 2010

Theofol




Theofol may be available in the countries listed below.


Ingredient matches for Theofol



Theophylline

Theophylline monohydrate (a derivative of Theophylline) is reported as an ingredient of Theofol in the following countries:


  • Finland

International Drug Name Search

Wednesday, 27 October 2010

biperiden


bye-PER-i-den


Commonly used brand name(s)

In the U.S.


  • Akineton

Available Dosage Forms:


  • Tablet

Therapeutic Class: Antiparkinsonian


Pharmacologic Class: Anticholinergic


Uses For biperiden


Biperiden is used alone or together with other medicines (e.g., levodopa) to treat Parkinson's disease. By improving muscle control and reducing stiffness, biperiden allows more normal movements of the body as the disease symptoms are reduced.


Biperiden is also used to control severe muscle reactions and other side effects from certain medicines that are used to treat severe nausea or nervous, mental, or emotional conditions (e.g., chlorpromazine [Thorazine®], perphenazine [Trilafon®], prochlorperazine [Compazine®], promethazine [Phenergan®], thioridazine [Mellaril®]).


biperiden is available only with your doctor's prescription.


Before Using biperiden


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For biperiden, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to biperiden or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of biperiden in the pediatric population. Safety and efficacy have not been established.


Geriatric


No information is available on the relationship of age to the effects of biperiden in geriatric patients. However, elderly men are more likely to have age-related prostate problems, which may require caution for patients receiving biperiden.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking biperiden, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using biperiden with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Potassium

Using biperiden with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Betel Nut

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of biperiden. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bowel blockage or

  • Glaucoma, narrow-angle or

  • Megacolon (colon is enlarged)—Should not be used in patients with these conditions.

  • Enlarged prostate or

  • Epilepsy (seizures) or

  • Glaucoma or

  • Heart rhythm problems—Use with caution. May make these conditions worse.

Proper Use of biperiden


Take biperiden every day exactly as ordered by your doctor in order to improve your condition as much as possible. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


You may take biperiden with food to reduce stomach irritation.


Dosing


The dose of biperiden will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of biperiden. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablets):
    • For side effects caused by other medicines:
      • Adults—2 milligrams (mg) one to three times per day.

      • Children—Use and dose must be determined by your doctor.


    • For Parkinson's disease:
      • Adults—At first, 2 milligrams (mg) three or four times per day. Your doctor may increase your dose as needed. However, the dose is usually not more than 16 mg per day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of biperiden, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using biperiden


It is important that your doctor check your progress at regular visits to allow changes in your dose and to check for any unwanted effects.


If you develop any unusual or strange thoughts and behavior while receiving biperiden, be sure to discuss it with your doctor. Some changes that have occurred in people receiving biperiden are like those seen in people who drink too much alcohol. Other changes might be confusion, worsening of depression, visual hallucinations (seeing things that are not there), suicidal thoughts, and unusual excitement, nervousness, or irritability.


Biperiden may cause drowsiness, trouble with controlling movements, or trouble with thinking or seeing clearly. Make sure you know how you react to biperiden before you drive, use machines, or do other jobs that require you to be alert, well-coordinated, or able to think or see well.


biperiden will add to the effects of alcohol and other CNS depressants (medicines that make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates or medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are taking biperiden.


biperiden Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Incidence not known
  • Anxiety

  • chest pain or discomfort

  • chills

  • cold sweats

  • confusion

  • confusion about identity, place, and time

  • decrease in frequency of urination

  • decrease in urine volume

  • difficulty in passing urine (dribbling)

  • disturbed behavior

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position

  • dry mouth

  • false or unusual sense of well-being

  • hyperventilation

  • irregular heartbeats

  • irregular, twisting uncontrolled movement of the face, hands, arms, or legs

  • irritability

  • nervousness

  • painful urination

  • restlessness

  • shaking

  • shortness of breath

  • slow or irregular heartbeat

  • trouble sleeping

  • unusual tiredness

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Change in consciousness

  • chest pain or discomfort

  • convulsions

  • decreased awareness or responsiveness

  • decreased secretions of the mouth, pharynx, nose, or bronchi

  • delusions of persecution, mistrust, suspiciousness, or combativeness

  • dizziness

  • dry mouth

  • enlarged pupils

  • face is warm or hot to touch

  • fainting

  • fast, slow, pounding, or irregular heartbeat or pulse

  • foul-smelling breath

  • holding false beliefs that cannot be changed by fact

  • lightheadedness

  • loss of consciousness

  • loss of memory

  • no breathing

  • redness to face

  • seeing, hearing, or feeling things that are not there

  • severe sleepiness

  • shakiness and unsteady walk

  • trouble sitting still

  • unsteadiness, trembling, or other problems with muscle control or coordination

  • unusual excitement, nervousness, or restlessness

  • warm, dry skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Incidence not known
  • Blurred vision

  • difficulty having a bowel movement (stool)

  • drowsiness

  • nausea

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: biperiden side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More biperiden resources


  • Biperiden Side Effects (in more detail)
  • Biperiden Dosage
  • Biperiden Use in Pregnancy & Breastfeeding
  • Biperiden Drug Interactions
  • Biperiden Support Group
  • 0 Reviews for Biperiden - Add your own review/rating


  • biperiden Concise Consumer Information (Cerner Multum)

  • Biperiden MedFacts Consumer Leaflet (Wolters Kluwer)

  • Biperiden Professional Patient Advice (Wolters Kluwer)

  • Biperiden Hydrochloride Monograph (AHFS DI)



Compare biperiden with other medications


  • Extrapyramidal Reaction
  • Parkinson's Disease

Sunday, 24 October 2010

Céforanide




Céforanide may be available in the countries listed below.


Ingredient matches for Céforanide



Ceforanide

Céforanide (DCF) is also known as Ceforanide (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 21 October 2010

rivastigmine


riv-a-STIG-meen


Commonly used brand name(s)

In the U.S.


  • Exelon

Available Dosage Forms:


  • Solution

  • Capsule

Therapeutic Class: Central Nervous System Agent


Pharmacologic Class: Cholinesterase Inhibitor, Centrally Acting


Uses For rivastigmine


Rivastigmineis used to treat the symptoms of mild to moderate Alzheimer's disease. Rivastigmine will not cure Alzheimer's disease, and it will not stop the disease from getting worse. However, rivastigmine can improve thinking ability in some patients with Alzheimer's disease.


In Alzheimer's disease, many chemical changes take place in the brain. One of the earliest and biggest changes is that there is less of a chemical called acetylcholine (ACh). ACh helps the brain to work properly. Rivastigmine slows the breakdown of ACh, so it can build up and have a greater effect. However, as Alzheimer's disease gets worse, there will be less and less ACh, so rivastigmine may not work as well.


rivastigmine is available only with your doctor's prescription.


Before Using rivastigmine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For rivastigmine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to rivastigmine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Studies on rivastigmine have been done only in adult patients, and there is no specific information comparing use of rivastigmine in children with use in other age groups.


Geriatric


Studies on rivastigmine have been done only in middle-aged and older patients. Information on the effects of rivastigmine is based on these patients.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking rivastigmine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using rivastigmine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Metoclopramide

Using rivastigmine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Oxybutynin

  • Tolterodine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of rivastigmine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Asthma (or history of) or

  • Blockage in the intestines or stomach, or

  • Heart problems, including slow heartbeat or hypotension (low blood pressure), or

  • Stomach ulcer (or history of) or

  • Urinary tract blockage or difficult urination—Rivastigmine may make these conditions worse

  • Epilepsy or history of seizures or

  • Diabetes, hormone, or thyroid problems that are poorly controlled—Rivastigmine may cause seizures

Proper Use of rivastigmine


Take rivastigmine only as directed by your doctor.Do not take more or less of it, and do not take it more or less often than your doctor ordered. Taking too much may increase the chance of side effects, while taking too little may not improve your condition.


Rivastigmine is best taken with food.


Rivastigmine seems to work best when it is taken at regularly spaced times, usually two times a day, in the morning and evening.


Dosing


The dose of rivastigmine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rivastigmine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For treatment of Alzheimer's disease:
      • Adults—To start, 1.5 milligrams (mg) twice a day. Your doctor may increase your dose gradually if you are doing well on rivastigmine. However, the dose is usually not more than 6 mg twice a day.



Missed Dose


If you miss a dose of rivastigmine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using rivastigmine


It is very important that your doctor check your progress at regular visits.


Tell your doctor if your symptoms get worse, or if you notice any new symptoms.


Before you have any kind of surgery, dental treatment, or emergency treatment, tell the doctor medical doctor or dentist in charge that you are taking rivastigmine. Taking rivastigmine together with medicines that are sometimes used during surgery or dental or emergency treatments may increase the effects of these medicines.


Rivastigmine may cause some people to become dizzy, clumsy, or unsteady. Make sure you know how you react to rivastigmine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.


Rivastigmine causes a large number of patients to have problems with their stomachs and intestines. Tell your doctor about any nausea, vomiting, stomach pain or loss of appetite.


Do not stop taking rivastigmine or decrease your dose without first checking with your doctor. Stopping rivastigmine suddenly or decreasing the dose by a large amount may cause mental or behavior changes.


If you think you or someone else may have taken an overdose of rivastigmine, get emergency help at once. Taking an overdose of rivastigmine may lead to convulsions (seizures) or shock. Some signs of shock are large pupils, irregular breathing, and fast weak pulse. Other signs of an overdose are severe nausea and vomiting, increasing muscle weakness, greatly increased sweating, and greatly increased watering of the mouth.


rivastigmine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


More common
  • Diarrhea

  • indigestion

  • loss of appetite

  • loss of strength

  • nausea and vomiting

  • weight loss

Less common
  • High blood pressure

  • fainting

Rare
  • Aggression

  • convulsions (seizures)

  • trembling and shaking of hands and fingers

  • trouble in urinating

Symptoms of overdose
  • Seizures

  • fast weak pulse

  • greatly increased sweating

  • greatly increased watering of mouth

  • irregular breathing

  • increasing muscle weakness

  • large pupils

  • low blood pressure

  • nausea

  • slow heartbeat

  • vomiting (severe)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach pain or cramping

  • bloated full feeling

  • confusion

  • constipation

  • mental depression

  • dizziness

  • fatigue

  • headache

  • seeing, hearing, or feeling things that are not there

  • trouble in sleeping

Less common
  • General feeling of discomfort or illness

  • increased sweating

  • runny nose

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: rivastigmine side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More rivastigmine resources


  • Rivastigmine Side Effects (in more detail)
  • Rivastigmine Use in Pregnancy & Breastfeeding
  • Rivastigmine Drug Interactions
  • Rivastigmine Support Group
  • 6 Reviews for Rivastigmine - Add your own review/rating


  • Rivastigmine Prescribing Information (FDA)

  • Rivastigmine Professional Patient Advice (Wolters Kluwer)

  • Rivastigmine Monograph (AHFS DI)

  • Rivastigmine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Exelon Prescribing Information (FDA)

  • Exelon Consumer Overview



Compare rivastigmine with other medications


  • Alzheimer's Disease
  • Parkinson's Disease

Thursday, 14 October 2010

Hyperhes




Hyperhes may be available in the countries listed below.


Ingredient matches for Hyperhes



Hetastarch

Hetastarch is reported as an ingredient of Hyperhes in the following countries:


  • France

International Drug Name Search

Saturday, 9 October 2010

Cicloviral




Cicloviral may be available in the countries listed below.


Ingredient matches for Cicloviral



Acyclovir

Aciclovir is reported as an ingredient of Cicloviral in the following countries:


  • Colombia

  • Portugal

International Drug Name Search

Cefalonium




In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0005575-21-3

Chemical Formula

C20-H18-N4-O5-S2

Molecular Weight

458

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

3-(4-Carbamoylpyridylmethyl)-8-oxo-7-[alpha-(thien-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Foreign Names

  • Cefalonium (Latin)
  • Cefalonium (German)
  • Cefalonium (French)
  • Cefalonio (Spanish)

Generic Names

  • Cefalonium (OS: BAN)
  • Cephalonium (OS: BAN)
  • Lilly 41071 (IS)
  • Cefalonium (PH: BP vet. 2008, BP vet. 2008)

Brand Names

  • Cefamaster (veterinary use)
    Merial Ancare, New Zealand


  • Cepravin (veterinary use)
    Essex Tierarznei, Poland; Intervet, France; Intervet / Schering-Plough Animal Health, New Zealand; Schering-Plough Animal, Luxembourg; Schering-Plough Animal Health, South Africa; Schering-Plough Vet, Italy; Schering-Plough Vet, Netherlands; Schering-Plough Veterinária, Lda, Portugal; Schering-Plough Veterinary, United Kingdom; Schering-Plough Veterinary, United Kingdom


  • Cepha Forte (veterinary use)
    Bomac, New Zealand


  • Cepravin (veterinary use)
    Schering-Plough Animal Health, Australia; Schering-Plough Animal Health, Belgium

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 7 October 2010

Quinapril Generichealth




Quinapril Generichealth may be available in the countries listed below.


Ingredient matches for Quinapril Generichealth



Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril Generichealth in the following countries:


  • Australia

International Drug Name Search

Wednesday, 6 October 2010

Gris-PEG


Gris-PEG is a brand name of griseofulvin, approved by the FDA in the following formulation(s):


GRIS-PEG (griseofulvin, ultramicrocrystalline - tablet; oral)



  • Manufacturer: PEDINOL

    Approved Prior to Jan 1, 1982

    Strength(s): 125MG, 250MG [RLD]

Has a generic version of Gris-PEG been approved?


No. There is currently no therapeutically equivalent version of Gris-PEG available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gris-PEG. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Gris-PEG.

See also...

  • Gris-PEG Ultramicrosize Tablets Consumer Information (Wolters Kluwer)
  • Gris-PEG Consumer Information (Cerner Multum)
  • Gris-PEG Advanced Consumer Information (Micromedex)
  • Griseofulvin Microsize Oral Suspension Consumer Information (Wolters Kluwer)
  • Griseofulvin Microsize Tablets Consumer Information (Wolters Kluwer)
  • Griseofulvin Ultramicrosize Tablets Consumer Information (Wolters Kluwer)
  • Griseofulvin Consumer Information (Cerner Multum)
  • Griseofulvin Advanced Consumer Information (Micromedex)
  • Griseofulvin AHFS DI Monographs (ASHP)

Protogyn




Protogyn may be available in the countries listed below.


Ingredient matches for Protogyn



Tinidazole

Tinidazole is reported as an ingredient of Protogyn in the following countries:


  • Bahrain

  • Bangladesh

  • Iraq

  • Jordan

  • Lebanon

  • Libya

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Monday, 27 September 2010

Miolox




Miolox may be available in the countries listed below.


Ingredient matches for Miolox



Meloxicam

Meloxicam is reported as an ingredient of Miolox in the following countries:


  • Argentina

International Drug Name Search

Friday, 24 September 2010

Kestin




Kestin may be available in the countries listed below.


Ingredient matches for Kestin



Ebastine

Ebastine is reported as an ingredient of Kestin in the following countries:


  • France

International Drug Name Search

Monday, 20 September 2010

Acid A Vit




Acid A Vit may be available in the countries listed below.


Ingredient matches for Acid A Vit



Tretinoin

Tretinoin is reported as an ingredient of Acid A Vit in the following countries:


  • Netherlands

International Drug Name Search

Friday, 17 September 2010

Ranflutin




Ranflutin may be available in the countries listed below.


Ingredient matches for Ranflutin



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Ranflutin in the following countries:


  • Bulgaria

International Drug Name Search

Tuesday, 14 September 2010

Cidomycin




In the US, Cidomycin is a member of the drug class aminoglycosides and is used to treat Bacteremia, Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Brucellosis, Burns - External, Cystic Fibrosis, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Meningitis, Pelvic Inflammatory Disease, Peritonitis, Plague, Pneumonia, Rabbit Fever, Skin Infection and Surgical Prophylaxis.

UK matches:

  • Cidomycin Adult Injectable 80mg/2ml (sanofi-aventis) (SPC)

Ingredient matches for Cidomycin



Gentamicin

Gentamicin is reported as an ingredient of Cidomycin in the following countries:


  • Tunisia

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Cidomycin in the following countries:


  • Bahrain

  • Ethiopia

  • Israel

  • Oman

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 12 September 2010

Baricol




Baricol may be available in the countries listed below.


Ingredient matches for Baricol



Barium Sulfate

Barium Sulfate is reported as an ingredient of Baricol in the following countries:


  • Luxembourg

International Drug Name Search

Friday, 3 September 2010

Fortamet


Fortamet is a brand name of metformin, approved by the FDA in the following formulation(s):


FORTAMET (metformin hydrochloride - tablet, extended release; oral)



  • Manufacturer: ANDRX LABS LLC

    Approval date: April 27, 2004

    Strength(s): 1GM [RLD][AB], 500MG [AB2]

Has a generic version of Fortamet been approved?


A generic version of Fortamet has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Fortamet and have been approved by the FDA:


metformin hydrochloride tablet, extended release; oral



  • Manufacturer: LUPIN LTD

    Approval date: June 29, 2011

    Strength(s): 1GM [AB], 500MG [AB2]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fortamet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Controlled release oral tablet having a unitary core
    Patent 6,099,859
    Issued: August 8, 2000
    Inventor(s): Cheng; Xiu Xiu & Chen; Chih-Ming & Jan; Steve & Chou; Joseph
    Assignee(s): Andrx Pharmaceuticals, Inc.
    A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane.
    Patent expiration dates:

    • March 20, 2018
      ✓ 
      Drug product




  • Controlled release oral tablet having a unitary core
    Patent 6,495,162
    Issued: December 17, 2002
    Inventor(s): Xiu Xiu; Cheng & Chih-Ming; Chen & Steve; Jan & Joseph; Chou
    Assignee(s): Andrx Pharmaceuticals, Inc.
    A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane.
    Patent expiration dates:

    • March 20, 2018
      ✓ 
      Drug product




  • Methods for treating diabetes via administration of controlled release metformin
    Patent 6,790,459
    Issued: September 14, 2004
    Inventor(s): Xiu Xiu; Cheng & Chih-Ming; Chen & Steve; Jan & Joseph; Chou
    Assignee(s): Andrx Labs, LLC
    A method for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at a 5.5 to 7.5 hours after oral administration on a once-a-day basis to human patients. Preferably, the dose of drug is administered at dinnertime to a patient in the fed state.
    Patent expiration dates:

    • March 17, 2021
      ✓ 
      Patent use: METHOD OF LOWERING BLOOD GLUCOSE BY ONCE DAILY ADMINISTRATION




  • Controlled release metformin compositions
    Patent 6,866,866
    Issued: March 15, 2005
    Inventor(s): Chen; Chih-Ming & Cheng; Xiu-Xiu & Jan; Steve & Chou; Joseph
    Assignee(s): Andrx Labs, LLC
    A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at 5.5 to 7.5 hours after oral administration on a once-a-day basis to human patients. Preferably, the dose of drug is administered at dinnertime to a patient in the fed state.
    Patent expiration dates:

    • March 17, 2021
      ✓ 
      Drug product




  • Controlled release metformin formulations
    Patent 7,919,116
    Issued: April 5, 2011
    Inventor(s): Chen; Chih-Ming & Cheng; Xiu Xiu & Jan; Steve & Chou; Joseph
    Assignee(s): Andrx Labs, LLC
    Sustained release pharmaceutical formulations comprising an antihyperglycemic drug or a pharmaceutically acceptable salt thereof are disclosed. The formulations provide therapeutic plasma levels of the antihyperglycemic drug to a human patient over a 24 hour period after administration.
    Patent expiration dates:

    • March 20, 2018
      ✓ 
      Drug product



See also...

  • Fortomet Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Fortamet Consumer Information (Cerner Multum)
  • Fortamet Advanced Consumer Information (Micromedex)
  • Metformin Consumer Information (Drugs.com)
  • Metformin Consumer Information (Wolters Kluwer)
  • Metformin Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Metformin Solution Consumer Information (Wolters Kluwer)
  • Metformin Consumer Information (Cerner Multum)
  • Metformin Advanced Consumer Information (Micromedex)
  • Metformin Hydrochloride AHFS DI Monographs (ASHP)

Ramipril Pliva




Ramipril Pliva may be available in the countries listed below.


Ingredient matches for Ramipril Pliva



Ramipril

Ramipril is reported as an ingredient of Ramipril Pliva in the following countries:


  • Croatia (Hrvatska)

International Drug Name Search

Wednesday, 1 September 2010

Kacin




Kacin may be available in the countries listed below.


Ingredient matches for Kacin



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Kacin in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 31 August 2010

Ceftazidina




Ceftazidina may be available in the countries listed below.


Ingredient matches for Ceftazidina



Ceftazidime

Ceftazidime is reported as an ingredient of Ceftazidina in the following countries:


  • Peru

International Drug Name Search

Saturday, 28 August 2010

Fixical vitamine D3




Fixical vitamine D3 may be available in the countries listed below.


Ingredient matches for Fixical vitamine D3



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Fixical vitamine D3 in the following countries:


  • France

Colecalciferol

Colecalciferol is reported as an ingredient of Fixical vitamine D3 in the following countries:


  • France

International Drug Name Search

Wednesday, 25 August 2010

Kovan




Kovan may be available in the countries listed below.


Ingredient matches for Kovan



Vancomycin

Vancomycin is reported as an ingredient of Kovan in the following countries:


  • Chile

International Drug Name Search

Tuesday, 24 August 2010

Leptazine




Leptazine may be available in the countries listed below.


Ingredient matches for Leptazine



Trifluoperazine

Trifluoperazine hydrochloride (a derivative of Trifluoperazine) is reported as an ingredient of Leptazine in the following countries:


  • Venezuela

International Drug Name Search

Monday, 23 August 2010

Flunixin N-Vet




Flunixin N-Vet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Flunixin N-Vet



Flunixin

Flunixin meglumine (a derivative of Flunixin) is reported as an ingredient of Flunixin N-Vet in the following countries:


  • Sweden

International Drug Name Search

Sunday, 22 August 2010

Acide Tiaprofénique Arrow




Acide Tiaprofénique Arrow may be available in the countries listed below.


Ingredient matches for Acide Tiaprofénique Arrow



Tiaprofenic Acid

Tiaprofenic Acid is reported as an ingredient of Acide Tiaprofénique Arrow in the following countries:


  • France

International Drug Name Search

Saturday, 21 August 2010

Amlodipino Placasod




Amlodipino Placasod may be available in the countries listed below.


Ingredient matches for Amlodipino Placasod



Amlodipine

Amlodipine mesilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipino Placasod in the following countries:


  • Spain

International Drug Name Search

Friday, 20 August 2010

Peroxacne




Peroxacne may be available in the countries listed below.


Ingredient matches for Peroxacne



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Peroxacne in the following countries:


  • Spain

International Drug Name Search

Tuesday, 17 August 2010

Anastrozol Sandoz




Anastrozol Sandoz may be available in the countries listed below.


Ingredient matches for Anastrozol Sandoz



Anastrozole

Anastrozole is reported as an ingredient of Anastrozol Sandoz in the following countries:


  • Switzerland

International Drug Name Search

Friday, 13 August 2010

Mirimostim




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0121547-04-4

Chemical Formula

C1058-H1651-N277-O341-S14

Molecular Weight

24157

Therapeutic Category

Immunomodulator

Chemical Name

1-214-Colony-stimulating factor 1 (human clone p3ACSF-69 protein moiety reduced), homodimer

Foreign Names

  • Mirimostimum (Latin)
  • Mirimostim (German)
  • Mirimostim (French)
  • Mirimostim (Spanish)

Brand Names

  • Leukoprol
    JCR Pharmaceuticals, Japan; Kyowa Hakko Kirin, Japan

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 10 August 2010

Getzol




Getzol may be available in the countries listed below.


Ingredient matches for Getzol



Albendazole

Albendazole is reported as an ingredient of Getzol in the following countries:


  • Colombia

International Drug Name Search

Cefradur




Cefradur may be available in the countries listed below.


Ingredient matches for Cefradur



Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Cefradur in the following countries:


  • Turkey

Cefradine

Cefradine is reported as an ingredient of Cefradur in the following countries:


  • Peru

  • Portugal

International Drug Name Search

Monday, 9 August 2010

Tramadol Ciclum




Tramadol Ciclum may be available in the countries listed below.


Ingredient matches for Tramadol Ciclum



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Ciclum in the following countries:


  • Portugal

International Drug Name Search

Sunday, 8 August 2010

Curatrem




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Curatrem



Clorsulon

Clorsulon is reported as an ingredient of Curatrem in the following countries:


  • United States

International Drug Name Search

Friday, 6 August 2010

Urisol




Urisol may be available in the countries listed below.


Ingredient matches for Urisol



Flavoxate

Flavoxate hydrochloride (a derivative of Flavoxate) is reported as an ingredient of Urisol in the following countries:


  • India

International Drug Name Search

Ultracet


Ultracet is a brand name of acetaminophen/tramadol, approved by the FDA in the following formulation(s):


ULTRACET (acetaminophen; tramadol hydrochloride - tablet; oral)



  • Manufacturer: JANSSEN PHARMS

    Approval date: August 15, 2001

    Strength(s): 325MG;37.5MG [RLD][AB]

Has a generic version of Ultracet been approved?


A generic version of Ultracet has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ultracet and have been approved by the FDA:


TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (acetaminophen; tramadol hydrochloride tablet; oral)



  • Manufacturer: AMNEAL PHARMS

    Approval date: December 9, 2009

    Strength(s): 325MG;37.5MG [AB]


  • Manufacturer: CARACO

    Approval date: December 16, 2005

    Strength(s): 325MG;37.5MG [AB]


  • Manufacturer: MYLAN

    Approval date: September 26, 2008

    Strength(s): 325MG;37.5MG [AB]


  • Manufacturer: PAR PHARM

    Approval date: April 21, 2005

    Strength(s): 325MG;37.5MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: July 26, 2006

    Strength(s): 325MG;37.5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ultracet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Composition comprising a tramadol material and acetaminophen and its use
    Patent RE39221
    Issued: August 1, 2006
    Inventor(s): Raffa; Robert B. & Vaught; Jeffrey L.
    Assignee(s): Ortho-McNeil Pharmaceutical, Inc.
    This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
    Patent expiration dates:

    • August 9, 2011
      ✓ 
      Patent use: TREATMENT OF PAIN
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Ultracet Consumer Information (Drugs.com)
  • Ultracet Consumer Information (Wolters Kluwer)
  • Ultracet Consumer Information (Cerner Multum)
  • Ultracet Advanced Consumer Information (Micromedex)
  • Tramadol/Acetaminophen Consumer Information (Wolters Kluwer)
  • Acetaminophen and tramadol Consumer Information (Cerner Multum)
  • Tramacet Advanced Consumer Information (Micromedex)
  • Tramadol and acetaminophen Advanced Consumer Information (Micromedex)

Tuesday, 3 August 2010

Cefs-T




Cefs-T may be available in the countries listed below.


Ingredient matches for Cefs-T



Ceftriaxone

Ceftriaxone is reported as an ingredient of Cefs-T in the following countries:


  • India

Tazobactam

Tazobactam is reported as an ingredient of Cefs-T in the following countries:


  • India

International Drug Name Search

Monday, 2 August 2010

Colastin L




Colastin L may be available in the countries listed below.


Ingredient matches for Colastin L



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Colastin L in the following countries:


  • Turkey

International Drug Name Search

Concurat L




Concurat L may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Concurat L



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Concurat L in the following countries:


  • Germany

International Drug Name Search

Sunday, 1 August 2010

Omeprax




Omeprax may be available in the countries listed below.


Ingredient matches for Omeprax



Omeprazole

Omeprazole is reported as an ingredient of Omeprax in the following countries:


  • Chile

  • Colombia

  • Switzerland

International Drug Name Search

Acustop Cataplasma




Acustop Cataplasma may be available in the countries listed below.


Ingredient matches for Acustop Cataplasma



Flurbiprofen

Flurbiprofen is reported as an ingredient of Acustop Cataplasma in the following countries:


  • Singapore

International Drug Name Search

Saturday, 31 July 2010

Methotrexate Orifarm




Methotrexate Orifarm may be available in the countries listed below.


Ingredient matches for Methotrexate Orifarm



Methotrexate

Methotrexate is reported as an ingredient of Methotrexate Orifarm in the following countries:


  • Denmark

International Drug Name Search

Carboptic




In the US, Carboptic (carbachol ophthalmic) is a member of the drug class ophthalmic glaucoma agents and is used to treat Glaucoma, Intraocular Hypertension and Production of Miosis.

US matches:

  • Carboptic Drops

  • Carboptic

Ingredient matches for Carboptic



Carbachol

Carbachol is reported as an ingredient of Carboptic in the following countries:


  • United States

International Drug Name Search

Tuesday, 27 July 2010

Klarexyl




Klarexyl may be available in the countries listed below.


Ingredient matches for Klarexyl



Clarithromycin

Clarithromycin is reported as an ingredient of Klarexyl in the following countries:


  • Greece

International Drug Name Search

Sunday, 18 July 2010

Midecamicina




Midecamicina may be available in the countries listed below.


Ingredient matches for Midecamicina



Midecamycin

Midecamicina (DCIT) is also known as Midecamycin (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 16 July 2010

Cefaleksyna




Cefaleksyna may be available in the countries listed below.


Ingredient matches for Cefaleksyna



Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Cefaleksyna in the following countries:


  • Poland

International Drug Name Search

Thursday, 15 July 2010

Tretinoina




Tretinoina may be available in the countries listed below.


Ingredient matches for Tretinoina



Tretinoin

Tretinoina (DCIT) is known as Tretinoin in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 10 July 2010

Butamirate Citrate Norma




Butamirate Citrate Norma may be available in the countries listed below.


Ingredient matches for Butamirate Citrate Norma



Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Butamirate Citrate Norma in the following countries:


  • Greece

International Drug Name Search

Tuesday, 6 July 2010

Bonine for Kids


Pronunciation: SYE-kli-zeen
Generic Name: Cyclizine Chewable
Brand Name: Bonine for Kids


Bonine for Kids is used for:

Preventing and treating nausea, vomiting, and dizziness associated with motion sickness. It may also be used for other conditions as determined by your doctor.


Bonine for Kids is an anticholinergic. It works by blocking a chemical in the brain, which helps to reduce or prevent vomiting.


Do NOT use Bonine for Kids if:


  • you are allergic to any ingredient in Bonine for Kids

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Bonine for Kids:


Some medical conditions may interact with Bonine for Kids. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have lung or breathing problems (eg, asthma; chronic bronchitis; chronic obstructive pulmonary disease [COPD]; emphysema), shortness of breath, or difficulty breathing

  • if you have stomach, bowel, or bladder blockage, prostate problems (an enlarged prostate), difficulty urinating, glaucoma, or increased pressure in the eye

  • if you have recently had surgery

Some MEDICINES MAY INTERACT with Bonine for Kids. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sodium oxybate (GHB ) because severe drowsiness and prolonged sleep may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Bonine for Kids may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Bonine for Kids:


Use Bonine for Kids as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Bonine for Kids by mouth with or without food.

  • Chew Bonine for Kids thoroughly before swallowing.

  • For prevention of motion sickness, take Bonine for Kids at least 1 hour before travel or at the onset of symptoms.

  • If you miss a dose of Bonine for Kids and are using it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Bonine for Kids.



Important safety information:


  • Bonine for Kids may cause drowsiness or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Bonine for Kids with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Bonine for Kids; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Tell your doctor or dentist that you take Bonine for Kids before you receive any medical or dental care, emergency care, or surgery.

  • Do NOT take more than 3 tablets in 24 hours or use for longer than prescribed without checking with your doctor.

  • Bonine for Kids should not be used in CHILDREN younger than 6 years old without checking with a doctor; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Bonine for Kids while you are pregnant. It is not known if Bonine for Kids is found in breast milk. If you are or will be breast-feeding while you use Bonine for Kids, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Bonine for Kids:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Drowsiness; dry mouth.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Bonine for Kids side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include drowsiness; hallucinations; seizures; unusual excitability; very slow or shallow breathing.


Proper storage of Bonine for Kids:

Store Bonine for Kids at room temperature, below 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Bonine for Kids out of the reach of children and away from pets.


General information:


  • If you have any questions about Bonine for Kids, please talk with your doctor, pharmacist, or other health care provider.

  • Bonine for Kids is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Bonine for Kids. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Bonine for Kids resources


  • Bonine for Kids Side Effects (in more detail)
  • Bonine for Kids Use in Pregnancy & Breastfeeding
  • Bonine for Kids Drug Interactions
  • 0 Reviews for Bonine for Kids - Add your own review/rating


  • cyclizine Concise Consumer Information (Cerner Multum)



Compare Bonine for Kids with other medications


  • Motion Sickness
  • Nausea/Vomiting